Dr. Jitendra Singh lays Foundation for Rs 600 crore Orchid Bio-Pharma plant in Kathua
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The Alathur facility specializes in the production of Cephalosporin antibiotics
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
The company is focussed on increasing the capacity utilizations while controlling costs
Subscribe To Our Newsletter & Stay Updated